Medicare Drug Price Negotiation – Beneficiary Protections Including Prohibiting QALYs

AAHD and the Lakeshore Foundation have joined the MAPRx (Medicare Access for Patients Rx) Coalition letter to CMS on Medicare Drug Price Negotiation possible rules. The comments focus on beneficiary protections including prohibiting the use of QALY (Quality-Adjusted Life Years) methods. The April 14 MAPRx letter to CMS is here: PDF.